Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Meetings, Planning and Dissemination Grant: Infection and Immunity

McGill University

$10,000.00

The Eleventh International Congress on Toxoplasmosis

EF 2010-11

Résumé
* Toxoplasmosis is of significant concern to the health of Canadians. This opportunistic disease caused by the parasite Toxoplasma is widespread and often recrudesces in immuno-compromised HIV/AIDS patients. Also, infection during pregnancy causes disastrous birth defects. Toxoplasmosis is common since infection is caused by the consumption of contaminated undercooked meat, raw vegetables and water, and parasite presence in the Canadian meat supply chain is significant. 30% of Canadians are infected with Toxoplasma, and prevalence reaches 70% in regions of QC and NU and in the Inuits. In the US, the human and economic cost of toxoplasmosis is 7.7 Billion $ pa; this cost in Canada most likely approaches 1 Billion $ pa. Thus, from perspectives that directly affect Canadians, Toxoplasma is of significant relevance to the mandate of the CIHR III (general III mandate-related MPD application). * Canada is for the first time hosting the [11th] International Congress on Toxoplasmosis (Ottawa, June 25-29, 2011). Since 1990, this meeting gathers increasing numbers of preeminent researchers from Canada and all over the world with a keen interest in vaccine and drug development, and infection and immunity biology. This meeting has facilitated rapid progress in research on this pathogen and related parasites including malaria. Its objectives are to disseminate advances in the field, contribute to knowledge translation, foster collaborations and introduce trainees to the leaders in the field. This effort being in part led by Canadian researchers is helping to unravel the biology of infections by viruses and intracellular bacteria and parasites. For instance, attenuated Toxoplasma strains are being examined as vaccine platforms against many diseases, including cancer and HIV. * With the help of support from CIHR, the organizers of this Congress hope to bring together a dynamic cohort of researchers, clinicians, industry and public health officials in Canada in June 2011.
Programme
Meetings, Planning and Dissemination Grant: Infection and Immunity
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
228156
Name
Dzierszinski Florence S
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Meetings, Planning and Dissemination Grant: Infection and Immunity
Projecttitle
The Eleventh International Congress on Toxoplasmosis
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Meetings, Planning and Dissemination Grant: Infection and Immunity
Keyworddelim
Congenital Toxoplasmosis & Birth Defects; Food- And Waterborne Pathogens & Public Health; Hiv/Aids & Toxoplasmosis Co-Infections; International Conference In Infection & Immunity; Knowledge Dissemination And Translation
Abstract
* Toxoplasmosis is of significant concern to the health of Canadians. This opportunistic disease caused by the parasite Toxoplasma is widespread and often recrudesces in immuno-compromised HIV/AIDS patients. Also, infection during pregnancy causes disastrous birth defects. Toxoplasmosis is common since infection is caused by the consumption of contaminated undercooked meat, raw vegetables and water, and parasite presence in the Canadian meat supply chain is significant. 30% of Canadians are infected with Toxoplasma, and prevalence reaches 70% in regions of QC and NU and in the Inuits. In the US, the human and economic cost of toxoplasmosis is 7.7 Billion $ pa; this cost in Canada most likely approaches 1 Billion $ pa. Thus, from perspectives that directly affect Canadians, Toxoplasma is of significant relevance to the mandate of the CIHR III (general III mandate-related MPD application). * Canada is for the first time hosting the [11th] International Congress on Toxoplasmosis (Ottawa, June 25-29, 2011). Since 1990, this meeting gathers increasing numbers of preeminent researchers from Canada and all over the world with a keen interest in vaccine and drug development, and infection and immunity biology. This meeting has facilitated rapid progress in research on this pathogen and related parasites including malaria. Its objectives are to disseminate advances in the field, contribute to knowledge translation, foster collaborations and introduce trainees to the leaders in the field. This effort being in part led by Canadian researchers is helping to unravel the biology of infections by viruses and intracellular bacteria and parasites. For instance, attenuated Toxoplasma strains are being examined as vaccine platforms against many diseases, including cancer and HIV. * With the help of support from CIHR, the organizers of this Congress hope to bring together a dynamic cohort of researchers, clinicians, industry and public health officials in Canada in June 2011.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dzierszinski, Florence S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~